TetraLogic Pharmaceuticals Corporation
TLOG · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $15 | $13 | $55 | $5 |
| Short-Term Investments | $5 | $41 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $2 | $0 | $0 |
| Total Curr. Assets | $22 | $56 | $55 | $5 |
| Property Plant & Equip (Net) | $0 | $1 | $0 | $0 |
| Goodwill | $0 | $17 | $0 | $0 |
| Intangibles | $42 | $42 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $3 | $0 | $0 |
| Total NC Assets | $42 | $62 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $64 | $118 | $56 | $5 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $4 | $4 | $2 |
| Total Curr. Liab. | $4 | $5 | $5 | $3 |
| LT Debt | $28 | $27 | $0 | $5 |
| Deferred Rev, NC | $0 | $2 | $0 | $0 |
| Deferred Tax Liab, NC | $17 | $17 | $0 | $0 |
| Other NC Liab. | $21 | $31 | $0 | $65 |
| Total NC Liab. | $66 | $80 | $0 | $70 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | -$0 | -$3 | $0 | $0 |
| Total Liabilities | $70 | $85 | $5 | $73 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$176 | -$126 | -$90 | -$70 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $170 | $159 | $140 | $231 |
| Total Equity | -$6 | $33 | $51 | -$68 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $64 | $118 | $56 | $5 |
| Net Debt | $13 | $14 | -$55 | $0 |